Intralesional nivolumab in oral potentially malignant disorders: A phase 1 pilot study on safety, tolerability, and preliminary efficacy

Category Primary study
JournalJournal of Clinical Oncology
Year 2024
This article has no abstract
Epistemonikos ID: 16acc3788180b1d9b139a00b04ec4bc9f57b4b8c
First added on: Feb 18, 2025